| REGENERON PHARMACEUTICALS |
| USA |
| Gesundheit |
| US75886F1075 / 881535 |
| RGO (Frankfurt) / REGN (NASDAQ) |
| FRA:RGO, ETR:RGO, RGO:GR, NASDAQ:REGN |
| https://www.regeneron.com.. |
|
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and met..
>Volltext.. |
| 89660.72 Mio. EUR |
| 83811.95 Mio. EUR |
| 15329.38 Mio. EUR |
| 5122.89 Mio. EUR |
| 4370.67 Mio. EUR |
| 42.62 EUR |
| 2455.97 Mio. EUR |
| 3331.13 Mio. EUR |
| 4396.62 Mio. EUR |
| 1.5 |
| 22.84% |
| 9% |
| 3.18 EUR |
| 0.39% |
| 0.4% |
| 18.08.26 - 0.80548596€ 20.05.26 - 0.808306€ >weitere anzeigen... |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 42.079.439 Euro. |
| REGENERON |
| 16.11.26 |